Edgard Wehbe is a Nephrology physician affiliated with Wichita Clinic. OpenAlex indexes 37 publications with 614 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
818 N Emporia St
Suite310
Wichita, KS 672143729
Telephone
316-263-5891Registry record last updated 18 Apr 2013.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20253 payments
- Medtronic, Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80%Angiotensin receptor blocker (ARB)18.9%Losartan Potassium75%Losartan-Hydrochlorothiazide22%Valsartan3%Part D<11 patientsLoop diuretic14.2%Furosemide73%Bumetanide15%Torsemide12%Part D≥96 patients+ 14 more classes in this area
Metabolism & gastrointestinal
12.4%SGLT2 inhibitor3.7%Jardiance67%Farxiga33%Part D<11 patientsPotassium supplement2.7%Potassium Chloride100%Part D≥21 patients+ 6 more classes in this area
Musculoskeletal
2.8%Xanthine oxidase inhibitor2.8%Allopurinol100%Part D≥29 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Paraneoplastic Cast Nephropathy Associated With Pancreatic Mixed Acinar-Neuroendocrine Carcinoma: A Case Report
American Journal of Kidney Diseases
2019 - Presence and Outcomes of Kidney Disease in Patients with Pulmonary Hypertension
Clinical Journal of the American Society of Nephrology
2014 - Cardiorenal Outcomes After Slow Continuous Ultrafiltration Therapy in Refractory Patients With Advanced Decompensated Heart Failure
Journal of the American College of Cardiology
2012
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”